SANUWAVE Health (SNWV) news
Recent news
Sanuwave Health Q2 net income USD -700 thousand
AInvest Wire · Aug 6, 2026Sanuwave Health Q2 gross margin 76.2%
AInvest Wire · Aug 6, 2026Sanuwave Health reports preliminary Q2 2026 revenue of $9.6–$9.8 million, above high end of revised guidance
Sanuwave Health Inc. reported preliminary revenue for the second quarter of 2026 in the range of $9.6–$9.8 million, exceeding the upper end of its revised guidance [1]. The company had previously adjusted its revenue expectations for the quarter to reflect ongoing operational and market dynamics.…
AInvest Wire · Jul 13, 2026Sanuwave Health - market disruption impacting Ultramist system sales
Celularity, Inc. has completed the sale of its UltraMIST® Ultrasound Healing Therapy asset to Sanuwave Health, Inc. [OTC PINK: SNWV], granting Sanuwave partnership rights to Celularity’s wound care biologic product portfolio. This transaction aligns with Celularity’s strategic focus on surgical…
AInvest Wire · Jun 16, 2026Sanuwave Health - updates Q2 2026 revenue guidance to $8.5-$9.5 mln
AInvest Wire · Jun 16, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.